Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
Day One Biopharmaceuticals, Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
Elevation Oncology
Seagen Inc.
Sotio Biotech Inc.
AstraZeneca
Merck Sharp & Dohme LLC
ADC Therapeutics S.A.
Pfizer
Pfizer
Fusion Pharmaceuticals Inc.
pharmaand GmbH
Genmab
4D pharma plc
Bristol-Myers Squibb
MacroGenics
KitovPharma
National Institutes of Health Clinical Center (CC)
Tocagen Inc.
Seagen Inc.
CureOne
Celldex Therapeutics
University of California, Davis
University of Michigan Rogel Cancer Center
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)